Driver gene classification reveals a substantial overrepresentation of tumor suppressors among very large

Zeev Waks1, Omer Weissbrod1, Boaz Carmeli1

  • 1Machine Learning for Healthcare and Life Sciences, IBM Research - Haifa, Mount Carmel Campus, Israel.

Scientific Reports
|December 24, 2016
PubMed

Insights

Identifying rare cancer driver genes is crucial for diagnostics and drug development. Our new method, CARNAF, finds these elusive genes by integrating genomic data with gene properties, revealing novel cancer-related genes.

Area of Science:

  • Genomics
  • Cancer Biology
  • Bioinformatics

Background:

  • Identifying cancer driver genes is essential for advancing oncology diagnostics and therapeutic development.
  • Infrequently mutated driver genes are often missed in traditional tumor genome analyses due to limited sample sizes.

Purpose of the Study:

  • To develop a method for detecting rare cancer driver genes that evade conventional discovery techniques.
  • To functionally classify newly identified drivers and characterize features associated with driver genes.
  • To investigate the role of specific gene properties, such as size and function, in cancer causality.

Main Methods:

  • Integration of tumor genomics data with a broad range of gene-specific properties.
  • Development and application of the CAnceR geNe similarity-based Annotator and Finder (CARNAF) tool.
  • Feature analysis to identify characteristics of driver genes, including those encoding large chromatin-regulating proteins.

Main Results:

  • CARNAF successfully detected potentially novel cancer drivers missed by over a dozen previous large-scale studies.
  • Feature analysis identified a significant enrichment of known and putative tumor suppressors among very large, chromatin-regulating proteins.
  • The study highlights the importance of investigating large epigenetic regulators in cancer.

Conclusions:

  • The CARNAF approach effectively addresses sample size limitations in discovering rare cancer driver genes.
  • Very large, chromatin-regulating proteins represent a promising area for future cancer driver gene research.
  • Deeper characterization of these epigenetic regulators is needed to understand their role in cancer development.

Related Concept Videos

Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.2K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
4.0K
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
34.1K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.1K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.7K